查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941550

靜脈輸液治療市場規模、佔有率和趨勢分析報告：按服務、組件、提供者、最終用途、地區和細分市場預測（2026-2033 年）

Intravenous Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider (Mobile, Physical), By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

靜脈輸液療法市場概述

預計到 2025 年，全球靜脈輸液治療市場規模將達到 28.3 億美元，到 2033 年將達到 56.6 億美元。

預計從 2026 年到 2033 年，該行業將以 9.2% 的複合年成長率成長。這一成長歸因於糖尿病、心血管疾病、自體免疫疾病和癌症等慢性疾病的日益流行，健康和美容療法的日益普及，靜脈輸液療法診所的日益增多，以及該療法的易用性。

靜脈輸液療法需求的成長源自於人們的觀念從傳統的臨床照護轉向便利、個人化的健康選擇。例如，2025年8月，AquaPulse IV在維吉尼亞弗雷德里克斯堡推出了行動靜脈輸液服務，由執照醫療專業人員前往客戶的家中、職場和活動地點，提供客製化的補液和維生素輸注。這些發展表明，靜脈輸液療法正逐漸成為一種生活方式和預防保健方法的一部分，能夠在日常生活中提供快速恢復、能量補充和免疫支持。這些按需服務模式凸顯了健康服務領域對便利性和以病人為中心的照護日益成長的重視。

消費者對預防性健康、復健方案和個人化照護模式日益成長的興趣，正在推動靜脈輸液療法市場的擴張。除了傳統的補液和營養支持外，醫療機構還提供專業服務，以支持長期健康目標。例如，2025年5月，The Hydration Room推出了NAD+輸液會員計劃，提供分級劑量方案，旨在改善大腦健康、提升精力和延長壽命。該計劃提供臨床監督下的每月NAD+療法，劑量靈活，體現了以訂閱為基礎、個人化護理的更廣泛趨勢，強調連續性、便利性和預防性健康管理。這些創新，以及行動輸液服務和技術賦能的交付模式的發展，正在將靜脈輸液療法轉變為一種主流的健康選擇，涵蓋從急性康復到持續健康最佳化的各個階段。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場趨勢展望
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

4. 靜脈輸液療法市場：服務估算與趨勢分析

  • 服務市佔率變化分析（2025 年和 2033 年）
  • 按服務分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 免疫增強劑
  • 能量增強劑
  • 水合作用
  • 美麗與美學
  • 排毒
  • 長壽與抗老
  • 運動能力和競技水平
  • 偏頭痛和疼痛緩解
  • 壓力、睡眠和情緒支持
  • 流感和腸胃炎
  • 其他

第5章 靜脈輸液療法市場：依成分分類的估算與趨勢分析

  • 按組件分類的市佔率變化分析（2025 年和 2033 年）
  • 市場規模、預測和趨勢分析（按組件分類，2021-2033 年）
  • 醫療的
  • 非醫療

6. 靜脈輸液療法市場：按供應商分類的估算和趨勢分析

  • 提供者控制面板
  • 2025 年及 2033 年各供應商市佔率變化分析
  • 市場規模、預測與趨勢分析（按供應商分類，2021-2033 年）
  • 行動電信商
  • 實體提供者

7. 靜脈輸液療法市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市佔率變化分析（2025 年和 2033 年）
  • 市場規模、預測和趨勢分析（按最終用途分類，2021-2033 年）
  • 醫療保健提供者
  • 醫院和診所
  • 健康中心/水療中心
  • 居家醫療
  • 其他

8. 靜脈輸液療法市場：區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場：主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 參與公司概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/列表
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Otsuka Pharmaceutical Co., Ltd.
    • Grifols, SA
    • Vifor Pharma Management Ltd.
    • JW Life Science Corporation
    • Amanta Healthcare
    • NexGen Health
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • Drip Hydration
    • REVIV
Product Code: GVR-4-68040-076-0

IV Hydration Therapy Market Summary

The global intravenous hydration therapy market size was valued at USD 2.83 billion in 2025 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. This growth is attributed to the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, autoimmune conditions, and cancer, the growing popularity of wellness and beauty treatments, and the increasing availability of intravenous (IV) hydration therapy clinics, as well as the ease of use associated with this therapy.

The increasing demand for IV hydration therapy is driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

Growing consumer interest in preventive wellness, recovery solutions, and personalized care models is driving the expansion of the IV hydration therapy market. Beyond traditional hydration and nutrient replacement, providers are offering specialized services that support long-term health goals. For instance, in May 2025, Hydration Room introduced the NAD+ IV Membership with tiered dosing options aimed at enhancing brain health, energy, and longevity. By providing monthly access to clinically supervised NAD+ therapy in flexible doses, the program exemplifies a wider trend toward subscription-based, customized care that prioritizes consistency, convenience, and proactive health management. These innovations, along with the growth of mobile IV services and tech-enabled delivery models, are turning IV hydration therapy into a mainstream wellness option that serves both acute recovery and ongoing health optimization.

Global Intravenous Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous hydration therapymarket report based on service, component, provider, end-use, and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune Boosters
  • Energy Boosters
  • Hydration
  • Beauty/ Aesthetics
  • Detoxification
  • Longevity/ Antiaging
  • Performance/ Athletics
  • Migraine & Pain Relief
  • Stress/Sleep/Mood Support
  • Flu/Stomach
  • Others
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Medicated
  • Non-medicated
  • Provider Outlook (Revenue, USD Million, 2021 - 2033)
  • Mobile Providers
  • Physical Providers
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Wellness Centers and Spas
  • Home Healthcare
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Component
    • 1.2.3. Provider
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
      • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
      • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
      • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
      • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Pricing Analysis
    • 3.2.6. Emerging Trends
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Intravenous (IV) Hydration Therapy Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Service Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Immune Boosters
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Energy Boosters
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydration
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Beauty/ Aesthetics
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Detoxification
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Longevity/ Antiaging
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Performance/ Athletics
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Migraine & Pain Relief
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Stress/Sleep/Mood Support
    • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Flu/Stomach
    • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Intravenous (IV) Hydration Therapy Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Medicated
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Medicated
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Intravenous (IV) Hydration Therapy Market: Provider Estimates & Trend Analysis

  • 6.1. Provider Dashboard
  • 6.2. Provider Market Share Movement Analysis, 2025& 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Provider, 2021 to 2033 (USD Million)
  • 6.4. Mobile Providers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Physical Providers
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Intravenous (IV) Hydration Therapy Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. End Use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Wellness Centers & Spas
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Healthcare
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Intravenous (IV) Hydration Therapy Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market: Key Takeaways
  • 8.3. North America
    • 8.3.1. North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamic
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive insights
      • 8.3.2.4. U.S. Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamic
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive insights
      • 8.3.3.4. Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamic
      • 8.3.4.2. Regulatory framework
      • 8.3.4.3. Competitive insights
      • 8.3.4.4. Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamic
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive insights
      • 8.4.2.4. Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key country dynamic
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive insights
      • 8.4.3.4. UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamic
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive insights
      • 8.4.4.4. France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamic
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive insights
      • 8.4.5.4. Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamic
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive insights
      • 8.4.6.4. Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamic
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive insights
      • 8.4.7.4. Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamic
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive insights
      • 8.4.8.4. Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamic
      • 8.4.9.2. Regulatory framework
      • 8.4.9.3. Competitive insights
      • 8.4.9.4. Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamic
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive insights
      • 8.5.2.4. Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamic
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive insights
      • 8.5.3.4. China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamic
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive insights
      • 8.5.4.4. India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamic
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive insights
      • 8.5.5.4. South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamic
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive insights
      • 8.5.6.4. Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamic
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive insights
      • 8.5.7.4. Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Intravenous (IV) Hydration Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamic
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive insights
      • 8.6.2.4. Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamic
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive insights
      • 8.6.3.4. Argentina Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamic
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive insights
      • 8.7.2.4. South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamic
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive insights
      • 8.7.3.4. Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamic
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive insights
      • 8.7.4.4. UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamic
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive insights
      • 8.7.5.4. Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Baxter International Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. B. Braun Melsungen AG
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols, S.A.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma Management Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. JW Life Science Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Amanta Healthcare
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. NexGen Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Core IV Therapy, LLC
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Cryojuvenate UK Ltd.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Drip Hydration
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. REVIV
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 6 North America Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 7 North America Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 10 U.S Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 11 U.S Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 14 Canada Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 15 Canada Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 19 Mexico Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 23 Europe Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 24 Europe Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 27 Germany Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 28 Germany Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 29 Germany Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 30 UK Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 31 UK Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 32 UK Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 33 UK Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 34 France Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 35 France Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 36 France Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 37 France Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Italy Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 39 Italy Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 40 Italy Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 41 Italy Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Spain Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 43 Spain Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 44 Spain Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 45 Spain Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Sweden Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 47 Sweden Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 48 Sweden Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 49 Sweden Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 51 Denmark Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 52 Denmark Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 53 Denmark Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Norway Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 55 Norway Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 56 Norway Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 57 Norway Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 63 China Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 64 China Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 65 China Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 66 China Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Japan Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 68 Japan Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 69 Japan Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 70 Japan Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 71 India Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 72 India Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 73 India Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 74 India Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Australia Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 76 Australia Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 77 Australia Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 78 Australia Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Thailand Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 80 Thailand Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 81 Thailand Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 82 Thailand Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 84 South Korea Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 85 South Korea Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 86 South Korea Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Latin America Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 88 Latin America Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 89 Latin America Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 90 Latin America Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 91 Latin America Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Brazil Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 93 Brazil Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 94 Brazil Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 95 Brazil Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Argentina Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 98 Argentina Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 99 Argentina Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA Intravenous (IV) Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 101 MEA Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 103 MEA Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 104 MEA Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 107 South Africa Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 108 South Africa Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 115 UAE Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 116 UAE Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Intravenous (IV) Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Intravenous (IV) Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Intravenous (IV) Hydration Therapy market, by provider, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Intravenous (IV) Hydration Therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Intravenous (IV) Hydration Therapy market: Market outlook
  • Fig. 5 Intravenous (IV) Hydration Therapy market: Segment outlook
  • Fig. 6 Intravenous (IV) Hydration Therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Intravenous (IV) Hydration Therapy Market Driver Impact
  • Fig. 9 Intravenous (IV) Hydration Therapy market Restraint impact
  • Fig. 10 Intravenous (IV) Hydration Therapy market, Service outlook key takeaways (USD Million)
  • Fig. 11 Intravenous (IV) Hydration Therapy market: Service movement analysis (USD Million)
  • Fig. 12 Immune Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Energy Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hydration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Beauty/ Aesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Detoxification market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Longevity/ Antiaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Performance/ Athletics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Migraine & Pain Relief market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Stress/Sleep/Mood Support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Flu/Stomach market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Intravenous (IV) Hydration Therapy market, component outlook: Key takeaways (USD Million)
  • Fig. 24 Intravenous (IV) Hydration Therapy market: component movement analysis (USD Million)
  • Fig. 25 Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Intravenous (IV) Hydration Therapy market, provider outlook key takeaways (USD Million)
  • Fig. 28 Intravenous (IV) Hydration Therapy market: provider movement analysis (USD Million)
  • Fig. 29 Mobile Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Physical Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Intravenous (IV) Hydration Therapy market, end use outlook key takeaways (USD Million)
  • Fig. 32 Intravenous (IV) Hydration Therapy market: end use movement analysis (USD Million)
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Wellness Centers & Spas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Home Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Intravenous (IV) Hydration Therapy market: Regional outlook, 2025 & 2033
  • Fig. 39 North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 U.S Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)